The Prognostic Value of the Tumor Shrinkage Rate for Progression-Free Survival in Patients with Non-Small Cell Lung Cancer Receiving Gefitinib
Main Authors: | , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620323/ |